Publication | Open Access
Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2
94
Citations
72
References
2020
Year
The MESV developed in this study is capable of generating immune response against COVID-19. Therefore, if designed MESV further investigated experimentally, it would be an effective vaccine candidate against SARS-CoV-2 to control and prevent COVID-19.
| Year | Citations | |
|---|---|---|
Page 1
Page 1